Corcept Therapeutics Inc
CORTNasdaqCIK 1088856HealthcareFiscal year ends Dec 31
Reports and events: 302 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-08-0216:14 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-026768 |
| 2023-08-0216:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-026757 |
| 2023-05-2416:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-23-019588 |
| 2023-05-0316:22 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001628280-23-015236 |
| 2023-05-0316:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-015219 |
| 2023-04-1416:16 ET | DEF 14A | Proxy statement | 0001628280-23-011628 |
| 2023-02-2816:31 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001628280-23-005581 |
| 2023-02-2816:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-005562 |
| 2023-02-1308:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-034374 |
| 2022-12-0808:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-300535 |
| 2022-11-0316:15 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001628280-22-028203 |
| 2022-11-0316:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-028184 |
| 2022-09-2216:33 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-22-249225 |
| 2022-08-0417:56 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001628280-22-020731 |
| 2022-08-0316:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-020614 |
| 2022-06-0217:20 ET | 8-K | 5.07 Shareholder vote results | 0001628280-22-016073 |
| 2022-05-0516:17 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001628280-22-012662 |
| 2022-05-0516:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-012652 |
| 2022-04-2516:37 ET | DEF 14A | Proxy statementPeriod 2022-04-25 | 0001628280-22-010131 |
| 2022-02-1516:22 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001628280-22-002714 |
| 2022-02-1516:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-002707 |
| 2021-12-0808:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-350898 |
| 2021-11-1517:07 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001193125-21-330090 |
| 2021-11-0316:26 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001628280-21-021485 |
| 2021-11-0316:22 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-21-021481 |
| 2021-08-1318:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-244963 |
| 2021-07-2916:31 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001628280-21-014900 |
| 2021-07-2916:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-21-014888 |
| 2021-06-1508:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-21-012220 |
| 2021-06-1013:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-21-011975 |
| 2021-06-0216:40 ET | 8-K | 5.07 Shareholder vote results | 0001628280-21-011522 |
| 2021-05-0616:21 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001628280-21-009318 |
| 2021-05-0616:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-21-009309 |
| 2021-04-2216:07 ET | DEF 14A | Proxy statementPeriod 2021-04-22 | 0001628280-21-007363 |
| 2021-03-0117:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-063823 |
| 2021-02-2317:09 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001628280-21-002861 |
| 2021-02-2316:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-21-002824 |
| 2021-02-0816:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-21-001612 |
| 2021-02-0308:31 ET | 8-K | 8.01 Other events | 0001193125-21-026522 |
| 2020-11-2317:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-20-016730 |
| 2020-11-1918:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-20-016580 |
| 2020-11-0316:46 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001628280-20-015376 |
| 2020-11-0316:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-20-015361 |
| 2020-08-0416:58 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001628280-20-011656 |
| 2020-08-0416:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-20-011643 |
| 2020-07-1417:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-20-010325 |
| 2020-05-2914:23 ET | 8-K | 5.07 Shareholder vote results | 0001628280-20-008606 |
| 2020-05-0417:06 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001628280-20-006270 |
| 2020-05-0416:27 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-20-006249 |
| 2020-04-2716:15 ET | DEF 14A | Proxy statementPeriod 2020-04-27 | 0001628280-20-005588 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:12 ET. Listed shows no prices and gives no investment advice.